Delivery Order SPE2DB22D1017-SPE2DB25FYRTC
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,316.60 to AmerisourceBergen Drug Corp for Varenicline 1 mg tablets (56-count packages) on August 28, 2025, with an ultimate completion date of August 29, 2025. This non-competitive, firm fixed-price delivery order represents a small-value pharmaceutical supply transaction executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be performed at the contractor's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Varenicline 1 mg tablets (56-count packaging) with a ceiling value of $4,207.84. This competitively awarded, firm fixed-price delivery order is not set-aside and will be fulfilled from the vendor's place of performance in Conshohocken, Pennsylvania, with an ultimate completion date of September 18, 2025. This delivery order is a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $7,432.57 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Varenicline 1 mg tablets (56-count units) on September 15, 2025, with an ultimate completion date of September 16, 2025. The contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a $1,007.15 delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Varenicline 1 mg tablets (56-count packages). This contract represents a firm fixed-price delivery order with an ultimate completion date of August 1, 2025, and carries no set-aside designation, indicating it was competitively awarded. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, the company's corporate headquarters location. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Varenicline 1 mg tablets (56-count packages) with a ceiling value of $3,388.33. This contract is structured as a firm fixed-price delivery order with an ultimate completion date of September 3, 2025, and represents a non-competitive set-aside award. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Varenicline 1 mg tablets (56-count packages) valued at $1,637.64. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 14, 2025, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation and represents a child contract under the vendor's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Varenicline 0.5 mg tablets (56-count packaging) with a ceiling value of $4,926.93. This competitively awarded contract utilizes firm fixed pricing and is not designated as a set-aside contract. The order is scheduled for ultimate completion on August 7, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Varenicline 1mg tablets (56-count packages) valued at $7,668.62, with completion scheduled for July 30, 2025. This competitive, firm fixed-price delivery order represents a routine pharmaceutical procurement supporting military healthcare operations. The award was issued under a non-set-aside competitive process, reflecting AmerisourceBergen's...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,381.37, is for the supply of 56-count tablets of the pharmaceutical drug Varenicline, which is used for smoking cessation. The contract has an ultimate completion date of June 10, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- The U.S. Defense Logistics Agency (DLA) awarded a $1,508.67 firm-fixed-price delivery order to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of 4565535452 VARENICLINE 1 MG TABLET 56S. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 between Amerisourcebergen and the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical and medical supplies to support military treatment programs and facilities...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FYRTCDelivery Order
The Defense Logistics Agency awarded a $3,523.36 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for Varenicline starting month box UU 53S, with completion targeted for September 24, 2025. This is a competitively awarded, non-set-aside contract with performance in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The underlying IDC vehicle provides comprehensive global pharmaceutical support, enabling the company to supply a broad range of medications, vaccines, medical devices, and specialized healthcare commodities to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. This specific delivery order for Varenicline—a smoking cessation medication—exemplifies the company's role in supplying essential pharmaceuticals across multiple therapeutic domains through the DLA's medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.5k | 9/23/25 |